Would BIO support a biosecurity bill targeting drug developers? Hear CEO John Crowley’s response

Two leaders on the House’s Select Committee on the CCP last week requested an intelligence briefing on the CDMO GenScript and its three related businesses over suspicions that the firms are linked to the Chinese government. Legend Biotech, as a subsidiary of GenScript, became part of the questioning. The move marks the first time that a drug developer has been publicly named as a potential target of interest in the ongoing biosecurity crackdown, and it raises the faintest possibility of a potential expansion of the proposed BIOSECURE Act.